Skip to main content
Log in

Difference in action between oral triazolam and zopiclone

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The effects of oral triazolam 0.25 mg and zopiclone 7.5 mg in 7 supine volunteers were compared by means of quantitative measurements of the EEG, saccadic eye movements, visual analogue scale (VAS) for alertness, critical flicker fusion frequency (CFF) and the Maddox wing.

Zopiclone reached its maximum effect earlier (62 min) than triazolam (91 min; CFF). On linear regression analysis the average rate constant (regression coefficient) of onset of action of zopiclone was significantly greater than that of triazolam (0.29 vs. 0.17).

Triazolam and zopiclone had similar effects, but zopiclone seemed to have a faster onset of action, probably indicating swifter absorption in supine subjects.

Quantitative EEG evaluation gave parallel results to the other parameters used, but triazolam and zopiclone showed a dissimilar mechanism of action, as characterized by changes in the alpha frequency.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Lindsley DB (1960) Attention, consciousness, sleep and wakefulness. In: Field J et al. (eds) Handbook of Physiology. Nagoun HW (section ed). Section 1: Neurophysiology. American Physiological Society, Washington DC

    Google Scholar 

  2. Fink M (1982) Quantitative pharmaco-EEG to establish dose-time relations in clinical pharmacology. In: Herrman WM (ed) Electroencephalography in drug research. Fischer, Stuttgart

    Google Scholar 

  3. Kunkel H (1982) On some hypotheses underlying pharmacoelectroencephalography. In: Herrman WM (ed) Electroencephalography in drug research. Fischer, Stuttgart

    Google Scholar 

  4. Matejcek M (1982) Vigilance and the EEG: Psychological, physiological and pharmacological aspects. In: Herrman WM (ed) Electroencephalography in drug research. Fischer, Stuttgart

    Google Scholar 

  5. Sittig W, Badian M, Rupp W, Taeuber K (1982) Performance tests and pharmaco-EEG after 1,4- and 1,5-benzodiazepines. In: Herrman WM (ed) Electroencephalography in drug research. Fischer, Stuttgart

    Google Scholar 

  6. Aschoff JC (1968) Veränderungen rascher Blickbewegungen (saccaden) beim Menschen unter Diazepam (Valium). Arch Psychiat Nervenkr 211: 325–332

    Google Scholar 

  7. Bittencourt PRM, Wade P, Smith AT, Richens A (1981) The relationship between peak velocity of saccadic eye movements and serum benzodiazepine concentration. Br J Clin Pharmacol (12): 523–533

  8. Hofferberth B (1986) Saccadic eye movements as a measure of residual effects: temazepam compared with other hypnotics. Acta Psychiatr Scand [Suppl] 74: 105–111

    Google Scholar 

  9. Salonen M, Aantaa E, Aaltonen L, Kanto J (1986) Importance of the interaction of midazolam and cimetidine. Acta Pharmacol Toxicol 58: 91–95

    Google Scholar 

  10. Friedman H, Greenblatt DJ, Burstein ES, Harmatz JS, Shader RI (1986) Population study of triazolam pharmacokinetics. Br J Clin Pharmacol 22: 639–642

    Google Scholar 

  11. Thomas D, Tipping T, Halifax R, Blogg CE, Hollands MA (1986) Triazolam premedication. Anaesthesia 41: 692–697

    Google Scholar 

  12. Goa KL, Heel RC (1986) Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic. Drugs 32: 48–65

    Google Scholar 

  13. Houghton G, Dennis M, Templeton R, Martin B (1985) A repeated dose pharmacokinetic study of a new hypnotic agent, zopiclone (Imovane®). Int J Clin Pharmacol Ther Toxicol (23): 97–100

  14. Autret E, Maillard F, Autret A (1987) Comparison of the clinical hypnotic effects of zopiclone and triazolam. Eur J Clin Pharmacol 31: 621–623

    Google Scholar 

  15. Warot D, Bensimon G, Danjou Ph, Puech AJ (1987) Comparative effects of zopiclone, triazolam and placebo on memory and psychomotor performance in healthy volunteers. Fund Clin Pharmacol 1: 145–152

    Google Scholar 

  16. Smith RB, Kroboth PD, Phillips JP (1986) Temporal variation in triazolam pharmacokinetics and pharmacodynamics after oral administration. J Clin Pharmacol 26: 120–124

    Google Scholar 

  17. Bond A, Lader M (1974) The use of analogue scales in rating subjective feelings. Br J Med Psychol 47: 211–218

    Google Scholar 

  18. Maxwell C (1978) Sensitivity and accuracy of the visual analogue scale: a psycho-physical classroom experiment. Br J Clin Pharmacol 6: 15–24

    Google Scholar 

  19. Smith JM, Misiak H (1976) Critical flicker frequency (CFF) and psychotropic drugs in normal human subjects — a review. Psychopharmacol (47): 175–182

  20. Hannington-Kiff JG (1970) Measurement of recovery from outpatient general anaesthesia with a simple ocular test. Br Med J 3: 132–135

    Google Scholar 

  21. Blanchard JC, Boireau A, Garret C (1984) Binding properties of zopiclone. Nord Psykiatr Tidsskr 10 [Suppl]: 21–27

    Google Scholar 

  22. Julou L, Blanchard JC, Dreyfus JF (1985) Pharmacological and clinical studies of cyclopyrrolones: Zopiclone and suriclone. Pharmacol Biochem Behav 23: 653–659

    Google Scholar 

  23. Smith RB, Kroboth PD, Varner PD (1987) Pharmacodynamics of triazolam after intravenous administration. J Clin Pharmacol 27: 971–979

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aantaa, R., Salonen, M. & Nyrke, T. Difference in action between oral triazolam and zopiclone. Eur J Clin Pharmacol 38, 47–51 (1990). https://doi.org/10.1007/BF00314802

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00314802

Key words

Navigation